Get started
Author

Berrin Pehlivan

Outcome and Prognostic Factors in Olfactory Neuroblastoma: A Rare Cancer Network Study
2010 · Mahmut Ozsahin, Guenther Gruber, et al. · International Journal of Radiation Oncology*Biology*Physics · 103
Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors
2023 · Erkan Topkan, Ahmet Kucuk, et al. · Journal of Clinical Medicine · 77
PDF
Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck
2018 · Pawel Golusinski, Pasquale Di Maio, et al. · Oral Oncology · 75
Temporal Lobe Toxicity Analysis After Proton Radiation Therapy for Skull Base Tumors
2012 · Berrin Pehlivan, Carmen Ares, et al. · International Journal of Radiation Oncology*Biology*Physics · 63
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
2011 · Erkan Topkan, Cem Parlak, et al. · BMC Gastroenterology · 59
PDF
Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide
2011 · Erkan Topkan, Savaş Topuk, et al. · American Journal of Clinical Oncology · 59
Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol
2020 · Erkan Topkan, Ahmet Kucuk, et al. · Journal of Immunology Research · 50
PDF
Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses
2009 · Cem Onal, Gungor Arslan, et al. · Journal of Experimental & Clinical Cancer Research · 49
PDF
Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas
2022 · Erkan Topkan, Ugur Selek, et al. · Journal of Inflammation Research · 37
PDF
Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
2012 · Erkan Topkan, Cem Parlak, et al. · BMC Cancer · 37
PDF
Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy
2020 · Erkan Topkan, Huseyin Mertsoylu, et al. · Gastroenterology Research and Practice · 34
PDF
Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients
2008 · Berrin Pehlivan, Charlotte Pichenot, et al. · Acta Oncologica · 31
PDF
Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma
2009 · Berrin Pehlivan, Erkan Topkan, et al. · Radiation Oncology · 29
PDF
The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
2023 · Erkan Topkan, Ugur Selek, et al. · Cancers · 28
PDF
Valero’s host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients
2023 · Erkan Topkan, Efsun Somay, et al. · BMC Cancer · 28
PDF
Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients
2023 · Busra Yilmaz, Efsun Somay, et al. · European Archives of Oto-Rhino-Laryngology · 24
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide
2020 · Erkan Topkan, Ali Ayberk Besen, et al. · Mediators of Inflammation · 22
PDF
A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer
2023 · Ahmet Kucuk, Erkan Topkan, et al. · International Journal of Immunopathology and Pharmacology · 17
PDF
Initial neutrophil‐to‐lymphocyte ratio predicts radiation‐induced trismus in parotid gland cancer
2022 · Efsun Somay, Busra Yilmaz, et al. · Oral Diseases · 17
Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers
2023 · Busra Yilmaz, Efsun Somay, et al. · Strahlentherapie und Onkologie · 16
The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
2023 · Busra Yilmaz, Efsun Somay, et al. · BMC Oral Health · 16
PDF
Hemoglobin‐to‐platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy
2022 · Efsun Somay, Busra Yilmaz, et al. · Oral Diseases · 16
Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis
2021 · Erkan Topkan, Ugur Selek, et al. · Journal of Oncology · 16
PDF
The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
2020 · Ahmet Kucuk, Emine Elif Ozkan, et al. · Journal of Oncology · 14
PDF
Sarcomatoid Carcinoma of the Urinary Bladder Treated with Adjuvant Radiotherapy: A Case Report
2009 · Cem Onal, Berrin Pehlivan, et al. · Clinical Medicine Case Reports · 14
Works count: 116
Citation count: 1,243
H-index: 17
I10-index: 39
Year
Topic
Type